Mounting evidence suggests that ZEB1 and miR-200c reciprocally control their expression through a negative regulatory loop, and miR-200c repression or ZEB1 expression has been associated with a worse prognosis in several carcinomas, such as breast and ovarian cancer5–7. The gene discussed is ZEB1; the disease is carcinoma.